Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (18)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  2. Prevalence and prognosis of anxiety, insomnia, and type D personality in patients with myocardial infarction: A Spanish cohort

    Cardiology journal, Vol. 31, Núm. 2, pp. 261-270

2023

  1. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  2. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  3. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  4. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  5. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  6. Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study

    Clinical Cardiology, Vol. 46, Núm. 11, pp. 1390-1397

  7. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  8. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  9. Takotsubo Syndrome, Stressful Triggers, and Risk of Recurrence

    American Journal of Cardiology, Vol. 205, pp. 58-62

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

2021

  1. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Frontiers in Medicine, Vol. 8

2019

  1. In-hospital postoperative infection after heart transplantation: Risk factors and development of a novel predictive score

    Transplant Infectious Disease, Vol. 21, Núm. 4

2018

  1. Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)

    International Journal of Clinical Practice, Vol. 72, Núm. 9

2010

  1. Factores pronósticos de mortalidad de la insuficiencia cardíaca en una cohorte del noroeste de España. Estudio EPICOUR

    Revista Clinica Espanola, Vol. 210, Núm. 9, pp. 438-447

2001

  1. Análisis del uso adecuado de los bloqueadores beta en el postinfarto

    Revista Espanola de Cardiologia, Vol. 54, Núm. 11, pp. 1277-1282